UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Targeting the Phosphatidylinositol 3‐Kinase Signaling Pathway in Breast Cancer

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (4), p.404-414

2011

Link zum Volltext

Verfügbarkeit prüfen

Palliative single‐fraction whole liver radiation therapy for diffuse liver metastases from metastatic Merkel cell carcinoma

Journal of dermatology, 2020-10, Vol.47 (10), p.e375-e376

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment response as predictor for brain metastasis in triple negative breast cancer: A score‐based model

The breast journal, 2019-05, Vol.25 (3), p.363-372

2019

Link zum Volltext

Verfügbarkeit prüfen

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma

Clinical cancer research, 2022-03, Vol.28 (6), p.1098-1106

2022

Link zum Volltext

Verfügbarkeit prüfen

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2628-2634

2011

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Systemic Therapies in Breast Cancer

The Surgical clinics of North America, 2013-04, Vol.93 (2), p.473-491

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

Cancer, 2012-03, Vol.118 (6), p.1498-1506

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma

Journal of clinical oncology, 2022-06, Vol.40 (17), p.1939-1948

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Clinical cancer research, 2018-11, Vol.24 (21), p.5250-5260

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment

The Journal of clinical investigation, 2021-10, Vol.131 (20), p.1-17

2021

Link zum Volltext

Verfügbarkeit prüfen

A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease

Respiratory medicine, 2013-09, Vol.107 (9), p.1385-1392

2013

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes

Radiotherapy and oncology, 2018-08, Vol.128 (2), p.266-273

2018

Link zum Volltext

Verfügbarkeit prüfen

Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.615-630

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast cancer research and treatment, 2021-08, Vol.189 (1), p.187-202

2021

Link zum Volltext

Verfügbarkeit prüfen

Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation

Annals of surgical oncology, 2011-10, Vol.18 (11), p.3164-3173

2011

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy principles of managing stage IV breast cancer in the United States

Chinese Clinical Oncology, 2016-06, Vol.5 (3), p.42-42

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation

Practical Radiation Oncology, 2020-05, Vol.10 (3), p.e128-e135

2020

Link zum Volltext

Verfügbarkeit prüfen

Why Chemotherapy Should be Given Early for Men with Metastatic Prostate Cancer

American Society of Clinical Oncology educational book, 2015 (35), p.e263-e269

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4454: Targeting the gp130 receptor in preclinical models of triple-negative breast cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4454-4454

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6130: Comprehensive genomic and transcriptomic profiling of acral lentiginous melanoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6130-6130

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5625: Molecular and immunologic characterization of HRAS mutations in a cohort of 6,329 patients with cutaneous melanoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5625-5625

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Taxanes in the Adjuvant Treatment of Breast Cancer

Breast diseases, 2010, Vol.21 (4), p.305-308

2010

Link zum Volltext

Verfügbarkeit prüfen

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e003272

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-16-03: Neoadjuvant treatment of triple negative breast cancer patients with docetaxel and carboplatin to assess anti-tumor activity

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-16-03

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Female
(14)
Oncology
(14)
Aged
(8)
Breast Cancer
(8)
Middle Aged
(8)
Adult
(7)
Treatment Outcome
(7)
Breast Neoplasms - Pathology
(5)
Cancer
(5)
Prognosis
(5)
Surgery
(5)
Aged, 80 And Over
(4)
Breast Neoplasms - Metabolism
(4)
Tumors
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Breast Neoplasms - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting the Phosphatidylinositol 3‐Kinase Signaling Pathway in Breast Cancer

Palliative single‐fraction whole liver radiation therapy for diffuse liver metastases from metastatic Merkel cell carcinoma

Treatment response as predictor for brain metastasis in triple negative breast cancer: A score‐based model

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer

Adjuvant Systemic Therapies in Breast Cancer

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers

Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma

Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment

A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease

Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer

Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes

Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation

Chemotherapy principles of managing stage IV breast cancer in the United States

Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation

Why Chemotherapy Should be Given Early for Men with Metastatic Prostate Cancer

Abstract 4454: Targeting the gp130 receptor in preclinical models of triple-negative breast cancer

Abstract 6130: Comprehensive genomic and transcriptomic profiling of acral lentiginous melanoma

Abstract 5625: Molecular and immunologic characterization of HRAS mutations in a cohort of 6,329 patients with cutaneous melanoma

The Role of Taxanes in the Adjuvant Treatment of Breast Cancer

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

Abstract P2-16-03: Neoadjuvant treatment of triple negative breast cancer patients with docetaxel and carboplatin to assess anti-tumor activity

Suchergebnisse filtern